淋巴瘤
医学
汽车T细胞治疗
肿瘤科
内科学
癌症研究
癌症
嵌合抗原受体
免疫疗法
作者
Mark Hamilton,Takeshi Sugio,Troy Noordenbos,Shuyu Shi,Philip L. Bulterys,Chih Long Liu,Xiaoman Kang,Mari Olsen,Zinaida Good,Saurabh Dahiya,Matthew Frank,Bita Sahaf,Crystal L. Mackall,Dita Gratzinger,Maximilian Diehn,Ash A. Alizadeh,David B. Miklos
标识
DOI：10.1056/nejmoa2401361
摘要
The risk of second tumors after chimeric antigen receptor (CAR) T-cell therapy, especially the risk of T-cell neoplasms related to viral vector integration, is an emerging concern.
科研通智能强力驱动
Strongly Powered by AbleSci AI
爱静静
寻道图强
乐乐乐乐乐乐
Frank
kento
yyymmma
樱桃猴子
fendy
Billy
jyy
zhouleiwang
浅尝离白
吃不饱星球球长
共享精神
领导范儿
shinysparrow
清脆松
tuanheqi
万能图书馆
sissiarno
皖公网安备34019202002308
